South Korea’s Celltrion Inc (068270.KS) has announced its plans to start in-human trials for coronavirus vaccine in late July. The officials reported that their experimental treatment demonstrated an up to 100-fold reduction in viral load of the disease in animal testing.

South Korea: Celltrion Inc to start COVID-19 drug tests in July

celltrion

Celltrion, News on Celltrion, stories on Celltrion, articles on Celltrion, Celltrion stories at Wion, Celltrion news, Celltrion latest news